| # | Drug | Count |
|---|---|---|
| 0 | DOCETAXEL | 5874 |
| 1 | DOCETAXEL ANHYDROUS | 5874 |
| 2 | TRASTUZUMAB | 1509 |
| 3 | DOXORUBICIN HYDROCHLORIDE | 1080 |
| 4 | LISINOPRIL | 837 |
| 5 | PAZOPANIB HYDROCHLORIDE | 834 |
| 6 | MINOXIDIL | 715 |
| 7 | CABOZANTINIB | 671 |
| 8 | CARBOPLATIN | 609 |
| 9 | ANASTROZOLE | 592 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEXIDARTINIB HYDROCHLORIDE | 236 | 0.3291 |
| 1 | DOCETAXEL | 5874 | 0.0863 |
| 2 | DOCETAXEL ANHYDROUS | 5874 | 0.0863 |
| 3 | SELENIUM SULFIDE | 55 | 0.0581 |
| 4 | TOVORAFENIB | 18 | 0.0552 |
| 5 | PEGFILGRASTIM | 401 | 0.0335 |
| 6 | DOXORUBICIN HYDROCHLORIDE | 1080 | 0.0327 |
| 7 | PAZOPANIB HYDROCHLORIDE | 834 | 0.0309 |
| 8 | TRASTUZUMAB | 1509 | 0.0217 |
| 9 | ERGOCALCIFEROL | 555 | 0.0187 |
| # | Drug class | Count |
|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 5883 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 1522 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1053 |
| 3 | Aromatase Inhibitor [EPC] | 970 |
| 4 | Benzodiazepine [EPC] | 905 |
| 5 | Arteriolar Vasodilator [EPC] | 781 |
| 6 | Corticosteroid [EPC] | 750 |
| 7 | Kinase Inhibitor [EPC] | 691 |
| 8 | Platinum-based Drug [EPC] | 618 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 571 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 5883 | 0.0355 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 1522 | 0.0203 |
| 2 | Provitamin D2 Compound [EPC] | 555 | 0.0187 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 112 | 0.0128 |
| 4 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 7 | 0.0116 |
| 5 | Arteriolar Vasodilator [EPC] | 781 | 0.0099 |
| 6 | Aromatase Inhibitor [EPC] | 970 | 0.0085 |
| 7 | Melanocortin 4 Receptor Agonist [EPC] | 2 | 0.0070 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 14 | 0.0067 |
| 9 | Amino Acid Hypertonic Solution [EPC] | 1 | 0.0063 |